Atara Biotherapeutics, Inc.
ATRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001604464
In the last 90 days, Atara Biotherapeutics, Inc. insiders filed 1 open-market purchase and 1 sale; 36 institutions reported holding it in 13F filings for Q2 2026, worth $51.3M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Atara Biotherapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 155 | 4 | 139 | −12 |
| Shares | 99.5M | 1.89M | 97.3M | −288.1K (−0.3%) |
| Value | $376.2M | $7.13M | $319.3M | −$49.8M (−13.5%) |
4 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Atara Biotherapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| M28 Capital Management LP | 439,300 | $1.44M | 1.37% |
| Healthcare of Ontario Pension Plan Trust Fund | 208,100 | $682.6K | 0.00% |
| Qube Research & Technologies Ltd | 55,997 | $183.7K | 0.00% |
| Alpine Global Management, LLC | 35,475 | $116.0K | 0.04% |
| Point72 Middle East FZE | 34,728 | $113.9K | 0.01% |
| Globeflex Capital L P | 25,783 | $84.6K | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 18,819 | $61.7K | 0.01% |
| American Century Companies Inc | 15,065 | $49.4K | 0.00% |
| Dimension Capital Management LLC | 14,000 | $45.9K | 0.01% |
| Beacon Pointe Advisors, LLC | 11,000 | $36.1K | 0.00% |
| Federated Hermes, Inc. | 170 | $558 | 0.00% |
| Advisory Services Network, LLC | 164 | $538 | 0.00% |
| Ellevest, Inc. | 18 | $59 | 0.00% |
Sold out (25)
Institutions that held Atara Biotherapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
Not filed for Q4 2022 yet (4)
Institutions that held Atara Biotherapeutics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $7.09M |
| American Portfolios Advisors | 4,500 | $17.0K |
| Wipfli Financial Advisors LLC, | 3,079 | $12.0K |
| ACT Capital Management, LLC | 900 | $3.00K |